Levothyroxine Treatment on Cardiac Function in Children With Subclinical Hypothyroidism
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 4 and 15 years old?
Source: NCT07393165, who can take part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Tanta University
- Trial code
- NCT07393165
- Record updated
- 6 February 2026
- Original description
This study aims to evaluate the effect of the treatment with levothyroxine on cardiac function in children with subclinical hypothyroidism.Read full original descriptionShow less
The Effect of Levothyroxine Treatment on Cardiac Function in Children With Subclinical Hypothyroidism
This study aims to evaluate the effect of the treatment with levothyroxine on cardiac function in children with subclinical hypothyroidism.
Inclusion: Age from 4 to 15 years; Both sexes; Patients with stable elevated thyroid-stimulating hormone (TSH) ≥ 4.5 mIU/L with normal free T4 and ft3 in different measurement 4 - 6 weeks apart.
Exclusion: Previous use of levothyroxine, antiepileptic drugs, or cardiac drugs within the last 6 months; Hypertension; Arrhythmia; Congenital or acquired heart disease; Liver or kidney disease; Diabetes; Infectious diseases; Respiratory diseases; Malignancies; Overweight and obesity; Hyperlipidemia.